Is VWF R924Q a benign polymorphism, a marker of a null allele or a factor VIII-binding defect? The debate continues with results from the UKHCDO VWD study

Thrombosis and Haemostasis

Volumn 100, Issue 4, 2008, Pages 716-718

  Lester, William ^a   Guilliatt, Andrea ^b   Grundy, Pamela ^c   Enayat, Said ^b   Millar, Carolyn ^d   Hill, Frank ^b   Cumming, Tony ^c   Collins, Peter ^e  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^b BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^c MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BLOOD CLOTTING FACTOR 8; VON WILLEBRAND FACTOR;

AMINO ACID SUBSTITUTION; BLEEDING; EXON; GEL ELECTROPHORESIS; GENE; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HUMAN; LETTER; NULL ALLELE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; SEQUENCE ANALYSIS; VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR GENE;

FAMILY HEALTH; GENETIC MARKERS; HEMOPHILIA A; HUMANS; POLYMORPHISM, GENETIC; VON WILLEBRAND FACTOR;

EID: 54949115050     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH08-04-0263     Document Type: Letter

References (9)

1. Hilbert L, Jorieux S, Proulle V, et al. Two novel mutations, Q1053H and C1060R, located in the D3 domain of von Willebrand factor, are responsible for decreased FVIII-binding capacity. Br J Haematol 2003; 120: 627-632.
2. Casais P, Carballo GA, Woods AI, et al. R924Q substitution encoded within exon 21 of the von Willebrand factor gene related to mild bleeding phenotype. Thromb. Haemost 2006; 96: 228-230.
3. James PD, Notley C, Hegadorn C, et al. The mutational spectrum of type 1 von Willebrand disease: Results from a Canadian cohort study. Blood 2007; 109: 145-154.
4. Goodeve A, Eikenboom J, Castaman G, et al. Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD). Blood 2007; 109: 112-121.
5. Cumming A, Grundy P, Keeney S, et al. An investigation of the von Willebrand factor genotype in UK patients diagnosed to have type 1 von Willebrand disease. Thromb Haemost 2006; 96: 630-641.
6. Ganguly A, Rock M J, Prockop D J. Conformation-sensitive gel electrophoresis for rapid detection of single-base differences in double-stranded PCR products and DNA fragments: evidence for solvent-induced bends in DNA heteroduplexes. Proc Natl Acad Sci USA 1993; 90: 10325-10329.
7. O'Brien L A, James P D, Othman M, et al. Founder von Willebrand factor haplotype associated with type 1 von Willebrand disease. Blood 2003; 102: 549-557.
8. Mannucci P M, Lattuada A, Castaman G, et al. Heterogeneous phenotypes of platelet and plasma von Willebrand factor in obligatory heterozygotes for severe von Willebrand disease. Blood 1989; 74: 2433-2436.
9. Peerlinck K, Eikenboom J C, Ploos van Amstel H K, et al. A patient with von Willebrand's disease characterized by a compound heterozygosity for a substitution of Arg854 by Gln in the putative factor-VIII-binding domain of von Willebrand factor (vWF) on one allele and very low levels of mRNA from the second vWF allele. Br J. Haematol 1992; 80: 358-363.